Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Cornely OA, Böhme A, Buchheidt D, Glasmacher A, Kahl C, Karthaus M, Kern W, Krüger W, Maschmeyer G, Ritter J, Salwender HJ, Sandherr M, Schiel X, Schüttrumpf S, Sieniawski M, Silling G, Ullmann AJ, Wolf HH; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Cornely OA, et al. Among authors: glasmacher a. Ann Hematol. 2003 Oct;82 Suppl 2:S186-200. doi: 10.1007/s00277-003-0773-3. Epub 2003 Sep 11. Ann Hematol. 2003. PMID: 13680164
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H; Itraconazole Research Group of Germany. Glasmacher A, et al. J Antimicrob Chemother. 2006 Feb;57(2):317-25. doi: 10.1093/jac/dki440. Epub 2005 Dec 8. J Antimicrob Chemother. 2006. PMID: 16339606 Clinical Trial.
Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Ruhnke M, Böhme A, Buchheidt D, Donhuijsen K, Einsele H, Enzensberger R, Glasmacher A, Gümbel H, Heussel CP, Karthaus M, Lambrecht E, Südhoff T, Szelényi H; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ruhnke M, et al. Among authors: glasmacher a. Ann Hematol. 2003 Oct;82 Suppl 2:S141-8. doi: 10.1007/s00277-003-0768-0. Epub 2003 Sep 11. Ann Hematol. 2003. PMID: 13680169
Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy.
Schuler U, Bammer S, Aulitzky WE, Binder C, Böhme A, Egerer G, Sandherr M, Schwerdtfeger R, Silling G, Wandt H, Glasmacher A, Ehninger G. Schuler U, et al. Among authors: glasmacher a. Onkologie. 2007 Apr;30(4):185-91. doi: 10.1159/000100055. Epub 2007 Mar 23. Onkologie. 2007. PMID: 17396041 Clinical Trial.
[Diagnosis of systemic fungal infections in hematology. Standard recommendations of the Working Group for Infections in Hematology and Oncology of the German Association for Hematology and Oncology].
Böhme A, Karthaus M, Einsele H, Ruhnke M, Südhoff T, Buchheidt D, Enzensberger R, Szelényi H, Glasmacher A, Just-Nübling G, Gümbel H. Böhme A, et al. Among authors: glasmacher a. Dtsch Med Wochenschr. 1999 Apr 9;124 Suppl 1:S24-30. Dtsch Med Wochenschr. 1999. PMID: 10410652 German. No abstract available.
Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy.
Ruhnke M, Rickerts V, Cornely OA, Buchheidt D, Glöckner A, Heinz W, Höhl R, Horré R, Karthaus M, Kujath P, Willinger B, Presterl E, Rath P, Ritter J, Glasmacher A, Lass-Flörl C, Groll AH; German Speaking Mycological Society; Paul-Ehrlich-Society for Chemotherapy. Ruhnke M, et al. Among authors: glasmacher a. Mycoses. 2011 Jul;54(4):279-310. doi: 10.1111/j.1439-0507.2011.02040.x. Mycoses. 2011. PMID: 21672038 Review.
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients.
Glasmacher A, Cornely OA, Orlopp K, Reuter S, Blaschke S, Eichel M, Silling G, Simons B, Egerer G, Siemann M, Florek M, Schnitzler R, Ebeling P, Ritter J, Reinel H, Schütt P, Fischer H, Hahn C, Just-Nuebling G. Glasmacher A, et al. J Antimicrob Chemother. 2006 Jan;57(1):127-34. doi: 10.1093/jac/dki410. Epub 2005 Nov 24. J Antimicrob Chemother. 2006. PMID: 16308418 Clinical Trial.
Clinical pharmacology of antifungal compounds.
Groll AH, Gea-Banacloche JC, Glasmacher A, Just-Nuebling G, Maschmeyer G, Walsh TJ. Groll AH, et al. Among authors: glasmacher a. Infect Dis Clin North Am. 2003 Mar;17(1):159-91, ix. doi: 10.1016/s0891-5520(02)00068-5. Infect Dis Clin North Am. 2003. PMID: 12751265 Review.
150 results